BMS-561392   Click here for help

GtoPdb Ligand ID: 6509

Synonyms: BMS 561392 | BMS561392 | DPC-333
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: TNF alpha converting enzyme inhibitor
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 117.78
Molecular weight 476.24
XLogP 3.73
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES ONC(=O)C(N1CCC(C1=O)(N)c1ccc(cc1)OCc1cc(C)nc2c1cccc2)CC(C)C
Isomeric SMILES ONC(=O)[C@H](N1CC[C@@](C1=O)(N)c1ccc(cc1)OCc1cc(C)nc2c1cccc2)CC(C)C
InChI InChI=1S/C27H32N4O4/c1-17(2)14-24(25(32)30-34)31-13-12-27(28,26(31)33)20-8-10-21(11-9-20)35-16-19-15-18(3)29-23-7-5-4-6-22(19)23/h4-11,15,17,24,34H,12-14,16,28H2,1-3H3,(H,30,32)/t24-,27-/m1/s1
No information available.
Summary of Clinical Use Click here for help
Potential treatment for overproduction of TNF alpha, such as rheumatoid arthritis (phase 2 trial) or inflammatory bowel disease [2]. Hoerver since this report there appears to have been no further development of this compound.